LABP-66

N/A

Report date: 2025/03/28 15:24:06
NME

Base Information

Drug NameLABP-66
Drug Alias NameLABP-66NX-66
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNLR family member X1 agonists
TargetsNLR family member X1
Therapy Area/IndicationsAlzheimer DiseaseMultiple Sclerosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusIND
Highest Status in ChinaN/A
Originator CompaniesLandos Biopharma Inc
China Registration ClassN/A

Develop Information

Active CompaniesLandos Biopharma Inc
Inactive CompaniesN/A
Active IndicationsAlzheimer DiseaseMultiple Sclerosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A